
Alphabet’s life sciences arm, Verily, is partnering with the digital pathology platform Lumea to improve the objectivity and efficiency of prostate cancer diagnosis, prognosis and therapy selection. Verily developed AI systems for…
Alphabet’s life sciences arm, Verily, is partnering with the digital pathology platform Lumea to improve the objectivity and efficiency of prostate cancer diagnosis, prognosis and therapy selection. Verily developed AI systems for…
Come and visit Lumea at UroGPO at booth 12 on March 31st for the Speciality Networks National Urology Conference.
Recent Comments